Ledger.Open graph →
SEC Form D · filed June 22, 2017

Rubius Therapeutics, Inc

Offering
$120.0M
Sold
$115.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Joseph Patrina · West Simsbury, CTExec · DirectorPeter B. Hutt · Watertown, MADirectorMichael Beaudoin · Newport Beach, CADirectorMichael S. Rosenblatt · Cambridge, MADirectorCrosby E. Howard · Palm Desert, CADirectorKathleen F. Briscoe · RENO, NVExecAllan Bernheimer · Pound Ridge, NYExecRoger S. Pomerantz · Cambridge, MADirectorKurt G. Deutsch · New York, NYDirectorChristine M. Cvijic · Palo Alto, CADirectorStephen Socolof · San Diego, CADirectorPeter Sacco · Cambridge, MADirectorPeter B. Hutt · Waltham, MADirectorRichard Sapp · San Diego, CADirectorHarvey F. Lodish · Cambridge, MADirectorTim D. Walsh · RENO, NVExec · DirectorTorben S. Nissen · Cambridge, MAExec · DirectorJoanne Protano · Cambridge, MAExecRobert S. Langer · Cambridge, MADirectorPECO Property Group LLC · Park City, UTDirectorMark Ranalli · Cambridge, MADirectorNoubar B. Afeyan · Cambridge, MADirectorHarvey F. Lodish · Cambridge, MADirectorDavid S. Epstein · Cambridge, MADirectorSteve E. Nelson · Palm Desert, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗